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Lead (Pb), a toxic contaminant metal used
in many important industrial processes, is
widely used in batteries, paint, and var-
nishes, as an antiknock compound in gaso-
line, in pipe covering, and in welding.
Because of its persistence in the environ-
ment, exposure to lead has become a major
public health concern. Chronic, low-level
exposure to lead affects children living in old
homes and/or children in families with low
income (1), as well as other groups that are
occupationally exposed to high lead levels.
The study of these highly exposed persons
provides the opportunity to establish rela-
tionships between exposure levels and differ-
ent toxic end points.
Although lead toxicity on different bio-
logical systems and functions has been well
reported (2–4), there are conﬂicting data on
its genotoxic and carcinogenic properties. In
bacterial tests, lead seems to be generally
nonmutagenic (5). Nevertheless, in eukary-
otic cells this metal is usually genotoxic
(6,7), through a mechanism that until now
has not been well characterized and that pos-
sibly involves indirect damage to DNA,
affecting the stabilization of chromatin (8)
or interacting with repair processes (9).
Whether lead is carcinogenic to humans
is still not known. The International Agency
for Research on Cancer (IARC) classified
lead and inorganic lead compounds as possi-
ble human carcinogens (Group 2B) on the
basis of sufﬁcient evidence for carcinogenic-
ity in experimental animals but inadequate
evidence for carcinogenicity in humans (10).
A quantitative assessment of published data,
with workers heavily exposed to inorganic
lead, provides some evidence to support the
hypothesis of an association between stom-
ach and lung cancer and exposure to lead
(11), but this meta-analysis is limited signiﬁ-
cantly by the lack of information about
potential confounding factors.
To learn more about the possible rela-
tionship between lead exposure and genetic
risk, we investigated genetic damage
observed in a large group of Bulgarian work-
ers exposed to lead. The data were collected
in three periods (1992, 1993, and 1996) and
the frequency of micronuclei (MN) was the
genetic end point evaluated. MN is consid-
ered a reliable biomarker of genotoxic expo-
sure to both physical and chemical agents
(12), and increases in MN frequency indi-
cate exposure to clastogenic and/or aneu-
genic agents. In addition, cytogenetic end
points in peripheral blood lymphocytes have
been used as biomarkers for many years and
allow a reasonable epidemiological evalua-
tion of cancer predictivity (13).
Materials and Methods
Studied populations. Three independent
biomonitoring studies were conducted in the
years 1992, 1993, and 1996, examining the
genotoxic effects of lead exposure in a group
of workers from a Bulgarian storage battery
plant. The studies assessed cumulative expo-
sures by monitoring concentrations of lead
in blood and by cytogenetic monitoring with
the micronucleus assay in peripheral blood
lymphocytes. We sampled 181 men in three
sessions. The first sample included 16 con-
trols and 29 exposed, the second included 24
controls and 49 exposed, and the third, 38
controls and 25 exposed. The 103 workers
exposed to lead participating in the study
were employed in a storage battery plant
located in Pazardzik, Bulgaria. These men
were constantly exposed at their workplaces
to lead concentrations in air 2–15 times the
permissible exposure limit (0.05 mg/m3;
PEL). The control group of 78 males was
divided in two subgroups as follows: an
internal control group of 43 persons from
the administrative and maintenance staff
from the same plant and an external control
group of 35 persons recruited from a non-
contaminated plant in the same town. 
The questionnaire and clinical examina-
tion of all the individuals studied were per-
formed the same day as blood sampling by
occupational expert pathologists to select
the appropriate subjects for the study.
Individuals exposed to other genotoxic
agents were not included in the study, and
the exposed and control individuals were
matched for relevant factors such as age,
smoking, and drinking habits. Each donor
gave written consent before the investiga-
tions, and blood samples were collected and
manipulated in accordance with ethical
standards.
The lead concentrations in the blood of
each participant were determined by using
an AAS PerkinElmer 3030 device (Perkin-
Elmer, Norwalk, CT, USA) after flame
extraction the day after sampling.
Cell cultures and MN analysis. Blood
samples were obtained by venipuncture in
heparinized sterile tubes, coded, and sent
immediately to the laboratory where they
were processed. Lymphocyte cultures were
started by adding 0.5 mL of blood to 5 mL
RPMI-1640 medium (Sigma, St. Louis,
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Articles
To investigate whether occupational exposure to lead is genotoxic, we evaluated data from 103
lead-exposed workers and 78 matched controls. These data correspond to three different sampling
periods, and we measured genetic damage as increases in the frequency of binucleated cells with
micronuclei (BNMN) in peripheral blood lymphocytes. The levels of exposure were determined
according to the lead levels in blood. Clearly signiﬁcant increases in BNMN were observed in the
exposed groups when compared to the control group. In addition, for the overall population (n =
181), we observed a clear relationship between lead levels in blood and BNMN (r = 0.497; p <
0.001). When we examined four exposure levels—very low exposure (< 1.20 µM/L), low exposure
(1.20–1.91 µM/L), high exposure (1.92–2.88 µM/L), and very high exposure (> 2.88 µM/L)—we
found signiﬁcant differences in the genetic damage induction. We conclude that exposure to lev-
els of lead higher than 1.20 µM/L may pose an increase in genetic risk. In addition, our data show
that blood lead level is a good indicator of genetic damage induction. Key words: biomonitoring,
genotoxicity, lead-exposed workers, lymphocytes, micronucleus assay. Environ Health Perspect
109:295–298 (2001). [Online 5 March 2001]
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hemagglutinin (PHA; Gibco, Grand Island,
NY, USA), 15% fetal calf serum (Sigma),
and 1% penicillin and streptomycin.
The cultures were incubated at 37°C
and 5% CO2 for 72 hr. Cytokinesis was
blocked with 6 µg/mL cytochalasin B
(Sigma) added 44 hr after PHA stimulation.
Cells were harvested by centrifugation and,
after a mild hypotonic treatment with 3 mL
0.075 M KCl at 4°C and another centrifu-
gation, were fixed by adding 5 mL fixative
solution (methanol:glacial acetic acid, 3:1).
Then 50 µL formaldehyde were added dur-
ing the next hour. We next performed two
steps of centrifugation, with consequent ﬁx-
ation of the material as already described,
without adding any more formaldehyde.
Air-dried preparations were stained with 5%
Giemsa (Merck, Darmstad, Germany) for
15 min. MN were scored in 1,000 binucle-
ated lymphocytes per donor according to
Fenech (12).
To minimize variability, the same
experts performed all the microscopic analy-
ses during the study. All scoring was per-
formed blind, with no knowledge of the
samples origin.
Statistical methods. For the investiga-
tions done in 1992, 1993, and 1996, we
compared the distribution of BNMN and
the distribution of blood lead concentration
with the normal distribution by means of
the Kolmogorov-Smirnov test of goodness of
fit. Neither distribution departed signifi-
cantly from normality and therefore para-
metric tests were adequate for the statistical
analysis. For each independent study, the
effects of some factors on binucleated
micronuclei (BNMN) were simultaneously
assessed by analysis of variance (ANOVA).
These factors were occupational exposure,
smoking habits, and alcohol consumption,
with age of the subject considered as a
covariate. To determine the relationship
between lead exposure levels and BNMN,
we applied a multiple regression analysis to
the whole investigated population. This
analysis was carried out by using the
CSS:STATISTIC/W (StatSoft, Tulsa, OK,
USA) statistical package.
Results
Tables 1 and 2 show the characteristics of
the control and exposed groups, respectively.
Age of individuals, years in their employ-
ment, and smoking and drinking habits are
indicated. Lead levels in blood are also
shown. These results are presented for each
sampling period as well as for the pooled
data. Lead in blood for the exposed workers
was about three times higher than the values
obtained for the controls, indicating that the
exposure levels were high.
Table 3 shows the results of the MN
scoring, indicating both the average total
number of MN scored for 1,000 binucleated
cells, as well as the average of binucleated
cells presenting one or more MN. This sec-
ond measurement has been considered a
good parameter for measuring genotoxic
effects (14). The overall frequency of
BNMN in the pooled control was 20.24 ±
1.02, which is in good agreement with val-
ues usually reported for control populations.
When we compared BNMN from sam-
pling periods for controls, we found no dif-
ferences between 1992 and 1993 (p = 0.67),
1992 and 1996 (p = 0.32), or 1993 and
1996 (p = 0.52). Furthermore, when all the
controls were grouped as internal controls (n
= 43) and external controls (n = 35), the sta-
tistical analysis showed that the differences
were not statistically significant (p = 0.18).
Thus, the pooled data can be considered as a
good reference control.
When the overall control data for
BNMN were compared with the pooled
exposed data, the differences were signifi-
cant (p < 0.001), indicating a clear geno-
toxic effect of lead exposure. Figure 1 shows
the values of the exposed group compared
with both the internal and external control
groups. These differences between exposed
and controls were also observed for each of
the sampling periods (p < 0.001; p =
0.0017; and p < 0.001 for 1992, 1993, and
1996, respectively).
The genetic effects detected in the
exposed group are considered to be caused
by lead exposure. The average values of lead
in blood for the exposed and for the inter-
nal and external controls are indicated in
Figure 2. This figure demonstrates that,
despite the lack of significance for the
BNMN values between internal and exter-
nal controls, the values of lead in blood are
higher in the internal control (p =
0.000198). Nevertheless, both control val-
ues are significantly lower than values
observed in the exposed group (p < 0.001).
The multiple regression analysis indicated a
slight relationship between alcohol con-
sumption and BNMN (p = 0.052).
Figure 3 shows the relationship between
the levels of lead in blood and genotoxic
effects, as reflected by the BNMN values.
This figure provides data for both the con-
trol and the exposed individuals (n = 181). A
significant correlation (r = 0.49669; p <
0.001) was found between BNMN and lead
in blood, indicating a direct relationship
between lead levels in blood and genetic
damage induction.
To visualize better the relationship
between lead in blood (as a measurement of
exposure) and the frequency of BNMN (as a
measurement of genetic damage), we catego-
rized the donors in four groups, according to
their blood lead levels. These values are indi-
cated in Figure 4, where the four groups,
corresponding to very low exposure (< 1.20
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Table 1. Characteristics of the three control groups, with lead levels in blood (mean ± SE). 
No. of Age Years Smoking Alcohol Pb in blood
Year individuals (years) employed (cigarettes/day) (g/day)  (µM/L)
1992 16 43.81 ± 2.83 17.51 ± 2.76 10.00 ± 2.41 16.81 ± 3.99 0.52 ± 0.04
1993 24 40.42 ± 1.86 13.33 ± 1.87 9.58 ± 2.13 5.33 ± 2.48 0.87 ± 0.08
1996 38 42.34 ± 1.38 16.71 ± 1.38 12.89 ± 2.02 7.58 ± 2.81 1.11 ± 0.06
Total 78 42.05 ± 1.05 15.83 ± 1.06 11.28 ± 1.28 8.78 ± 1.81 0.91 ± 0.04
Table 2. Characteristics of the three exposed groups, with lead levels in blood (mean ± SE). 
No. of Age Years Smoking Alcohol Pb in blood
Year individuals (years) employed (cigarettes/day) (g/day)  (µM/L)
1992 29 39.72 ± 1.56 11.09 ± 1.25 7.24 ± 1.76 13.24 ± 4.63 2.44 ± 0.21
1993 49 39.26 ± 1.28 8.83 ± 0.85 11.22 ± 1.26 13.71 ± 2.47 2.89 ± 0.14
1996 25 38.24 ± 2.03 9.72 ± 0.96 14.60 ± 1.98 14.08 ± 4.16 2.61 ± 0.16
Total 103 39.14 ± 0.89 9.68 ± 0.59 10.92 ± 0.94 13.67 ± 2.00 2.70 ± 0.10
Table 3. Mean number (± SE) of micronuclei (MN) in binucleated cells and binucleated cells presenting
one or more micronuclei (BNMN).
No. of
Group Year individuals MN BNMN 
Control 1992 16 19.68 ± 1.98 18.56 ± 1.78
1993 24 21.04 ± 1.95 19.71 ± 1.81
1996 38 23.08 ± 1.79 21.29 ± 1.60
Total 78 21.76 ± 1.13 20.24 ± 1.02
Exposed 1992 29 39.28 ± 2.36 34.59 ± 2.31
1993 49 35.47 ± 2.59 31.31 ± 2.32
1996 25 60.80 ± 3.65 52.32 ± 2.89
Total 103 42.69 ± 1.94 37.33 ± 1.68
We scored 1,000 binucleated cells per donor.µM/L), moderate exposure (1.20–1.91
µM/L), high exposure (1.92–2.88 µM/L),
and very high exposure (> 2.88 µM/L), are
shown. The number of donors in each group
was 71, 32, 29, and 49, respectively. As can
be seen, BNMN correlate well with blood
lead levels, obtaining significant differences
between very low and moderate exposure
levels (p = 0.05) and moderate and high
exposure levels (p = 0.02), although not
between the high exposure and the very high
exposure levels (p = 0.16).
Discussion
The workers occupationally exposed to lead
who were monitored in this investigation
showed clear evidence of genetic damage in
peripheral blood lymphocytes when evalu-
ated by using the MN assay. These results
extend and confirm our recent studies per-
formed in another group of Bulgarian work-
ers exposed to lead (15) with no apparent
exposure to other suspicious genotoxic
agents at the workplace.
Once the hazardous workplace or expo-
sures are identiﬁed, the major objectives are
to establish the relationship between expo-
sure levels and genetic risk and to deﬁne safe
levels of exposure on a sound toxicological
basis. In this context, biomonitoring
exposed individuals is extremely important,
especially in evaluating genotoxic effects, as
in this study. At present, large follow-up
studies suggest that increases in chromo-
some alterations may predict an increased
cancer risk (13,16).
Among the different cytogenetic
approaches, the MN assay in human lym-
phocytes using the cytokinesis-block method
(17) has increasingly been accepted as a reli-
able biomarker of cytogenetic damage
induced by genotoxic agents, both physical
and chemical (12,18). Positive findings
using this biomarker indicate evidence of
exposure to clastogenic and/or aneugenic
compounds. In particular, the MN assay has
proved very reliable in assessing the geno-
toxic effects of metal ions in occupational
exposures (15,19,20)
Regarding the carcinogenic risk of lead
exposure, several experiments in rats and
mice showed the production of renal tumors
when lead compounds were administered in
food and drinking water (21). In humans,
several epidemiological studies of workers
exposed to lead in various occupational set-
tings have been reported. Unfortunately,
most of these studies contain some deﬁcien-
cies, particularly a lack of information about
cumulative past exposures, and the overall
studies do not provide conclusive evidence
of an association between lead exposure and
increased incidence of cancer (10,21).
Accordingly, lead has been classified by
IARC as a possible human carcinogen on the
basis of sufficient evidence in rodents but
inadequate evidence in humans (10).
Nevertheless, a meta-analysis of published
data from workers highly exposed to lead
seems to support the hypothesis of an associ-
ation between exposure to lead and stomach
and lung cancer (11).
The relationship that exists between the
genotoxic and carcinogenic potential of lead
has been the subject of extensive studies,
although in most of them the results
obtained were inconclusive. Thus, although
lead seemed to be negative in an assay
detecting mutation induction in bacteria
(22), positive results were obtained in an
assay detecting induction of λ prophage in
E. coli (23). In mammalian cells, induction
of mutation has been reported in the hprt
locus in Chinese hamster V79 cells by lead
compounds (6), although studies on the
induction of chromosomal aberrations, both
in vivo and in vitro, showed ambiguous
results because the genotoxic response
appears to depend on factors such as cell
type, duration, and route of exposure and
can also be inﬂuenced by synergistic effects.
Thus, for instance, calcium-deﬁcient animals
exposed to lead demonstrated more severe
chromosomal aberrations than nondeﬁcient
animals (24). All these variables contribute
to the high variability in results. 
With respect to the biomonitoring stud-
ies performed in humans occupationally
exposed to lead, although relatively few
studies have examined the genotoxic poten-
tial of lead and they offer some equivocal
results, most show increases in chromoso-
mal aberrations (25–29). The high degree of
variability in the available data represents,
perhaps, different levels of exposure and
makes the explanation of biomonitoring
results quite complex.
In view of the current inconclusive evi-
dence of a direct relationship between in vivo
lead exposure and induction of genetic dam-
age, we think that the positive ﬁndings pre-
sented here are satisfactory evidence of a
genetic risk associated with lead exposure. It
must be remembered that the MN assay
detects both clastogenic and aneugenic effects,
covering a wider spectrum of damage than
the classical chromosome aberrations test.
Thus, it could be possible that lead induces
genotoxicity via induction of chromosome
loss, which would be interesting to conﬁrm.
Although the qualitative data obtained
are important, indicating a genetic risk asso-
ciated with lead exposure, more interesting is
the quantitative association found between
blood lead levels (as a measurement of expo-
sure) and BNMN (as a measurement of
genetic damage). The levels of genotoxins in
the body ﬂuids can be regarded as a measure
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Figure 1. BNMN values obtained for exposed and
controls (internal and external).
65
55
45
35
25
15
5
B
N
M
N
External Internal Exposed
Groups
Mean ±  SD
Mean ±  SE
Mean
Figure 2. Lead levels in blood from exposed and
controls (internal and external).
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Figure 3. Lead in blood and BNMN relationship in
the overall population. BNMN = 16.755 + 6.828
(blood lead); r = 0.49669.
Figure 4. Lead in blood and BNMN relationship for
four blood lead levels. 
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1.2–1.92 1.92–2.88 > 2.88of the internal dose, confirming that expo-
sure has indeed occurred. Cytogenetic alter-
ations as measured by the MN assay are early
biological effects in carcinogenesis, if we
assume that lymphocytes are valid surrogate
cells for the changes taking place in tissues
where neoplasms may eventually develop.
Nevertheless, the relationship between expo-
sure markers and genetic changes such as
chromosome alterations are not always clear
(30), depending on the toxicokinetics and
distribution of the compound or its metabo-
lites in the body compartments.
In our study, the large sample size and
the wide variability found in the blood lead
levels made it possible to obtain a good rela-
tionship between the exposure and the bio-
markers. This allowed us to identify
exposure levels as low as 1.20–1.91 µM/L,
which are associated with significant
increases of genetic damage at levels where
no clinical symptoms are observed. These
lead levels are found in the range reported
for different populations not specifically
exposed to lead at their workplace (31) and
exceed the biological tolerance value regu-
lated in many countries, (e.g., in Germany
this value is 3.38 µM/L) (32).
In summary, this study shows a clear
genotoxic effect associated with the occupa-
tional exposure to lead, indicating that this
effect is dose-related to the lead levels in
blood. These data are relevant and permit an
estimate of the genetic risk of lead exposure
by using biomarkers of exposure. 
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